Tatsuta's work demonstrates new methods for transforming carbohydrates, including innovative methods for the synthesis of deoxyglycosides that have significantly increased the value of carbohydrates as starting materials.
He has also synthesized several useful derivatives of natural products. Through total syntheses of glycosidase inhibitors, he demonstrated for the first time the theoretical possibilities of chemically creating inhibitors against all glycosidases and developed useful anti-diabetes agents. In addition, a new anticancer agent, THPadriamycin (commercialized as pirarubicin in 1988), was synthesized by him through his synthetic studies on anthracyclines. He also succeeded in synthesizing cefozopran, which was marketed in 1995. I would like to make special note of his particular contributions to the development of The Journal of Antibiotics, including the 75 papers that he has published in this Journal.
Tatsuta's extraordinary contributions to natural products chemistry have been repeatedly recognized, as indicated by his several awards and honors, including the Sumiki-Umezawa Memorial Award (1988), the Distinguished Award of the Chemical Society of Japan (2001), the National Medal with Purple Ribbon of Japan (2002), the Fujihara Award (2008), the Japan Academy Prize (2009) and the Special Award in Synthetic Organic Chemistry Japan (awarded in February, 2013) , as well as his honorary membership of the Chemical Society of Japan. This year, the American Chemical Society will also honor him with its prestigious Ernest Guenther Award.
